Vommi Lakshmipathy, S.; Vijayaraghavan Sathyanathan, C.; Dandapani Chinambedu, M.; Gopikrishnan, M.; Ponneri Adithavarman, A.; Thyagarajan, S.P.; Gnanambal Krishnan, M.E.
A Marine Anticancer Cinnamyloxyl Derivative with Unique Binding Sites at Carbonic Anhydrase IX (CAIX) Inhibits Adenocarcinomic A549 Cells. Pharmaceuticals 2026, 19, 132.
https://doi.org/10.3390/ph19010132
AMA Style
Vommi Lakshmipathy S, Vijayaraghavan Sathyanathan C, Dandapani Chinambedu M, Gopikrishnan M, Ponneri Adithavarman A, Thyagarajan SP, Gnanambal Krishnan ME.
A Marine Anticancer Cinnamyloxyl Derivative with Unique Binding Sites at Carbonic Anhydrase IX (CAIX) Inhibits Adenocarcinomic A549 Cells. Pharmaceuticals. 2026; 19(1):132.
https://doi.org/10.3390/ph19010132
Chicago/Turabian Style
Vommi Lakshmipathy, Shailaja, Christina Vijayaraghavan Sathyanathan, Mohanapriya Dandapani Chinambedu, Mohanraj Gopikrishnan, Abhinand Ponneri Adithavarman, Sadras Panchatcharam Thyagarajan, and Mary Elizabeth Gnanambal Krishnan.
2026. "A Marine Anticancer Cinnamyloxyl Derivative with Unique Binding Sites at Carbonic Anhydrase IX (CAIX) Inhibits Adenocarcinomic A549 Cells" Pharmaceuticals 19, no. 1: 132.
https://doi.org/10.3390/ph19010132
APA Style
Vommi Lakshmipathy, S., Vijayaraghavan Sathyanathan, C., Dandapani Chinambedu, M., Gopikrishnan, M., Ponneri Adithavarman, A., Thyagarajan, S. P., & Gnanambal Krishnan, M. E.
(2026). A Marine Anticancer Cinnamyloxyl Derivative with Unique Binding Sites at Carbonic Anhydrase IX (CAIX) Inhibits Adenocarcinomic A549 Cells. Pharmaceuticals, 19(1), 132.
https://doi.org/10.3390/ph19010132